Alpha Amylase as a Salivary Biomarker of Acute Stress of Venepuncture from Periodic Medical Examinations

Alpha Amylase as a Salivary Biomarker of Acute Stress of Venepuncture from Periodic Medical Examinations

Periodic occupational health examinations often require venepuncture. Acute psychological and physical stressors during such procedure result in sympathetic stimulation and increased salivary protein secretion, including salivary α-amylase (SAA). We studied SAA response to venepuncture during such examination. Fifty-eight healthy males undergoing periodic medical examination reported perceived ...

Is Salivary Alpha Amylase Useful as a Biomarker of Stress in Oral Diseases?

Although Salivary Alpha Amylase (SAA) has been investigated during past thirty years as a biomarker of stress, still remains certain doubt regarding its utility. Additionally, there has been a lot of debate whether SAA reflects sympathetic activity solely, however, recent data suggested that this is unlikely due to the parasympathetic activity which innervates salivary glands whose product is S...

Usefulness of salivary alpha amylase as a biomarker of chronic stress and stress related oral mucosal changes – a pilot study

INTRODUCTION Salivary biomarkers are suggested to provide a reliable, noninvasive and objective measurement of chronic psychosocial stress and helps in assessment of pivotal role of stress in causation or precipitation of multitude of health problems. OBJECTIVES To evaluate the usefulness of salivary alpha amylase activity as an objective indicator of chronic stress and to find out any correl...

Salivary Alpha-Amylase Activity, a New Biomarker in Heart Failure?

PM482. SALIVARY ALPHA-AMYLASE (sAA) AS A BIOMARKER FOR THE RESPONSE OF THERAPY IN SCHIZOPHRENIA PATIENTS

s | 75 Methods: International, multicenter, retrospective, observational study. Outcomes presented are patient characteristics, reason for PP initiation and hospitalization data. Results: 84 patients were analyzed: Mean age (years) at first psychotic episode was 23.8(SD2.6), 23.9(SD2.6) at first antipsychotic treatment and 24.1(SD2.7, range 19–29) at PP initiation. Time between first antipsycho...